Characterization of the renal renin-angiotensin system in transgenic mice that express rat tonin

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 4, 2015, Pages 947-955

  Ribeiro, Amanda A ^a   Palomino, Zaira ^a   Lima, Mércia P ^b   Souza, Leandro E ^c   Ferreira, Daniele S ^a   Pesquero, João B ^a   Irigoyen, Maria C ^c   Pesquero, Jorge L ^b   Casarini, Dulce E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; N domain ACE; Renal renin angiotensin system; Tonin; Transgenic mice

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; BETA ACTIN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN; TONIN; ANGIOTENSIN DERIVATIVE; ISOENZYME; TISSUE KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENETICS; KIDNEY; METABOLISM; SPRAGUE DAWLEY RAT; STAINING;

ANGIOTENSINS; ANIMALS; BLOTTING, WESTERN; ISOENZYMES; KIDNEY; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDYL-DIPEPTIDASE A; RATS, SPRAGUE-DAWLEY; RENIN; RENIN-ANGIOTENSIN SYSTEM; STAINING AND LABELING; TISSUE KALLIKREINS;

EID: 84952878052     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320315595572     Document Type: Article

References (54)

1. Peach MJ., Renin-angiotensin system: Biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313-370.
2. Siragy HM., Angiotensin II compartmentalization within the kidney: Effects of salt diet and blood pressure alterations. Curr Opin Nephrol Hypertens 2006; 15: 50-53.
3. Skeggs LT Jr, Kahn JR, Shumway NP., The preparation and function of the hypertensin-converting enzyme. J Exp Med 1956; 103: 295-299.
4. Skeggs LT Jr, Marsh WH, Kahn JR, et al. The existence of two forms of hypertensin. J Exp Med 1954; 99: 275-282.
5. Griendling KK, Murphy TJ, Alexander RW., Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.
6. Bader M, Ganten D., Update on tissue renin-angiotensin systems. J Mol Med 2008; 86: 615-621.
7. Kumar R, Singh VP, Baker KM., The intracellular renin-angiotensin system: Implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens 2008; 17: 168-173.
8. Paul M, Poyan Mehr A, Kreutz R., Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
9. Baltatu O, Lippoldt A, Hansson A, et al. Local renin-angiotensin system in the pineal gland. Mol Brain Res 1997; 54: 237-242.
10. Rosenthal J, Thurnreiter M, Plaschke M, et al. Reninlike enzymes in human vasculature. Hypertension 1990; 15: 848-853.
11. Saye JA, Ragsdale NV, Carey RM, et al. Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Am J Physiol 1993; 264 (6 Pt 1): C1570-C1576.
12. Boucher R, Asselin J, Genest J., A new enzyme leading to the direct formation of angiotensin II. Circ Res 1974; 35 (Suppl I): I-203-I-212.
13. Grisé C, Boucher R, Thibault G, et al. Formation of angiotensin II by tonin from partially purified human angiotensinogen. Can J Biochem 1981; 59: 250-255.
14. Urata H, Nishimura H, Ganten D., Chymase-dependent angiotensin II forming systems in humans. Am J Hypertens 1996; 9: 277-284.
15. Araujo GW, Pesquero JB, Lindsey CJ, et al. Identification of serine proteinases with tonin-like activity in the rat submandibular and prostate glands. Biochim Biophys Acta 1991; 1074: 167-171.
16. Araujo RC, Lima MP, Lomez ES, et al. Tonin expression in the rat brain and tonin-mediated central production of angiotensin II. Physiol Behav 2002; 76: 327-333.
17. Chao J, Chao L, Swain CC, et al. Tissue kallikrein in rat brain and pituitary: Regional distribution and estrogen induction in the anterior pituitary. Endocrinology 1987; 120: 475-482.
18. Gualberto MP, Nunes RL, Beraldo WT, et al. Tonin-like activity present in the human submandibular gland. Agents Actions Suppl 1992; 38 (Pt 1): 392-400.
19. Lomez ES, Araujo RC, Bader M, et al. Tonin and kallikrein in the brain of transgenic rat line expressing human tissue kallikrein. Hypertension 2002; 39: 229-232.
20. Lopes ES, Sumitani M, Juliano L, et al. Distribution of tonin-and kallikrein-like activities in rat brain. Brain Res 1997; 769: 152-157.
21. Boucher R, Saidi M, Genest J., A new “angiotensin converting enzyma system. In: Genest J, Koiw E, (eds) Hypertension. New York: Springer-Verlag, 1972, pp. 512-523.
22. Pesquero JL, Boschcov P, Oliveira MC, et al. Effect of substrate size on tonin activity. Biochem Biophys Res Commun 1982; 108: 1441-1446.
23. Schiffrin EL, Garcia R, Gutkowska J, et al. Pressor effect of tonin in anephric animals. Can J Physiol Pharmacol 1981; 59: 864-871.
24. Zacharatos DT, Vasak EZ, Cheng ES, et al. Immunohistochemistry of tonin in rat submandibular gland during development, lactation and secretion. Histochemistry 1983; 79: 433-442.
25. Boucher R, Garcia R, Gutkowska J, et al. Tonin-angiotensin II system in hypertension. Clin Sci Mol Med Suppl 1978; 4: 183s-186s.
26. Damasceno DD, Lima MP, Motta DF, et al. Cardiovascular and eletrocardiographic parameters after tonin administration in Wistar rats. Regul Pept 2013; 181: 30-36.
27. Cardoso CC, Alenina N, Ferreira AJ, et al. Increased blood pressure and water intake in transgenic mice expressing rat tonin in the brain. Biol Chem 2010; 391: 435-441.
28. Pacheco Dda F, Pacheco CM, Lima Mde P, et al. Antinociceptive response in transgenic mice expressing rat tonin. Eur J Pharmacol 2013; 713: 1-5.
29. Popova E, Bader M, Krivokharchenko A., Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production. Transgenic Res 2005; 14: 729-738.
30. Oliveira EM, Santos RA, Krieger JE., Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats. Braz J Med Biol Res 2000; 33: 755-764.
31. Friedland J, Silverstein E., A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976; 66: 416-424.
32. Ronchi FA, Irigoyen MC, Casarini DE., Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus. J Renin Angiotensin Aldosterone Syst 2007; 8: 34-41.
33. Laemmli UK., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
34. Kobori H, Nangaku M, Navar LG, et al. The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
35. Dzau VJ., Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77 (6 Pt 2): I4-I13.
36. Stock P, Liefeldt L, Paul M, et al. Local renin-angiotensin systems in cardiovascular tissues: Localization and functional role. Cardiology 1995; 86 (Suppl 1): 2-8.
37. Ketteler M, Noble NA, Border WA., Transforming growth factor-beta and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Ann Rev Physiol 1995; 57: 279-295.
38. Deddish PA, Marcic B, Jackman HL, et al. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: Angiotensin-(1-7) and keto-ACE. Hypertension 1998; 31: 912-917.
39. Yamada K, Iyer SN, Chappell MC, et al. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 1998; 32: 496-502.
40. Handa RK., Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. J Am Soc Nephrol 2000; 11: 1377-1386.
41. Kucharewicz I, Pawlak R, Matys T, et al. Angiotensin-(1-7): An active member of the renin-angiotensin system. J Physiol Pharmacol 2002; 53: 533-540.
42. Mei Wang PH, Andrade MC, Quinto BM, et al. N-domain angiotensin-I converting enzyme is expressed in immortalized mesangial, proximal tubule and collecting duct cells. Int J Biol Macromol 2015; 72: 380-390.
43. Fleming I, Kohlstedt K, Busse R., New fACEs to the renin-angiotensin system. Physiology (Bethesda) 2005; 20: 91-95.
44. Danilczyk U, Penninger JM., Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 2006; 98: 463-471.
45. Ferrario CM, Trask AJ, Jessup JA., Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005; 289: H2281-H2290.
46. Varagic J, Trask AJ, Jessup JA, et al. New angiotensins. J Mol Med 2008; 86: 663-671.
47. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-E9.
48. Ferreira AJ, Santos RA., Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 2005; 38: 499-507.
49. Edwards RM, Pullen M, Nambi P., Distribution of neutral endopeptidase activity along the rat and rabbit nephron. Pharmacology 1999; 59: 45-50.
50. Landry C, Santagata P, Bawab W, et al. Characterization of neutral endopeptidase 24.11 in dog glomeruli. Biochem J 1993; 291 (Pt 3): 773-779.
51. Bauer J, Berthold H, Schaefer F, et al. Quantification of conversion and degradation of circulating angiotensin in rats. Am J Physiol 1999; 277 (2 Pt 2): R412-R418.
52. Velez JC., The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Nephrol 2008; 5: 89-100.
53. Parvathy S, Oppong SY, Karran EH, et al. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer. Biochem J 1997; 327 (Pt 1): 37-43.
54. Aragão DS, de Andrade MC, Ebihara F, et al. Serine proteases as candidates for proteolytic processing of angiotensin-I converting enzyme. Int J Biol Macromol 2014; 72: 673-679.